Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00360451 · ClinicalTrials.gov registry record · Phase 3

Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents

A Phase 3 study, sponsored by University of Pennsylvania.

Completed
Registry status
Phase 3
Development phase
400
Enrollment target

NCT00360451: Completed Phase 3 study, sponsored by University of Pennsylvania.

NCT00360451 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00360451, a Phase 3 study, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
Phase 3
Development phase
400 participants
Enrollment target

Study Summary

This study will evaluate the effectiveness of the Penn Resiliency Program, a school-based cognitive behavioral depression prevention program for young adolescents.

Interventions

  • BEHAVIORAL Adolescent only Penn Resiliency Program (Adolescent PRP)
  • BEHAVIORAL Parent Penn Resiliency Program (Parent PRP)

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2002-09
Est. Completion 2008-03
Phase Phase 3

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT00360451

The ClinicalTrials.gov registry entry for NCT00360451 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Adolescent only Penn Resiliency Program (Adolescent PRP) is the first listed.

NCT00360451 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00360451 about?

NCT00360451 is a clinical study titled "Effectiveness of School-Based Cognitive Behavioral Therapy in Preventing Depression in Young Adolescents". This study will evaluate the effectiveness of the Penn Resiliency Program, a school-based cognitive behavioral depression prevention program for young adolescents.

What is the current status of trial NCT00360451?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 400 participants. The study started on 2002-09. Estimated completion is 2008-03.

What interventions are being tested in trial NCT00360451?

The interventions under investigation include: Adolescent only Penn Resiliency Program (Adolescent PRP) (BEHAVIORAL), Parent Penn Resiliency Program (Parent PRP) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00360451?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.